Jonathan Colasanti
Overview
Jonathan Colasanti, MD, MSPH received his medical degree from the University of Miami, Miller School of Medicine in 2008. Subsequently, he completed his Internal Medicine internship, Internal Medicine/Social Medicine and Global Health Equity residency, and public health degree at the University of Miami. He completed his Infectious Diseases fellowship at Emory University.
In 2015, Dr. Colasanti joined the Emory faculty as an assistant professor with a dual appointment in the School of Medicine (Department of Medicine, Division of Infectious Diseases) and the School of Public Health (Department of Global Health). He also serves as the Associate Medical Director of the Ponce de Leon Center, Infectious Diseases Program of the Grady Health System. His clinical and research interests focus on the delivery of HIV care to vulnerable populations, across the spectrum of the HIV care continuum. In his research, he seeks to bridge the implementation gap in order to improve the delivery of HIV care, by addressing sociobehavioral, biomedical, and systems-level barriers. In addition to his Atlanta-based work, he works with a Nicaraguan NGO that strives to improve the delivery of primary health care in Nicaragua through a community health worker model.
Academic Appointment
- Associate Professor of Medicine, Division of Infectious Diseases, Emory University School of Medicine
- Assistant Professor of Global Health, Global Health, Emory University Rollins School of Public Health
Education
Degrees
- Master of Science in Public Health from University of Miami Miller School of Medicine
- MD from University of Miami Miller School of Medicine
- BA Psychology from University of Virginia
Research
Publications
-
Long-acting cabotegravir/rilpivirine, lenacapavir, and ibalizumab use among persons with HIV-1 viremia at a Ryan White-funded clinic in the urban U.S. South.
Clin Infect Dis
08/01/2025 Authors: Colasanti JA; Aldredge A; Niles-Carnes LV; Ochieng E; Pareek P; Robinson V; Anderson E; Castaneda M; Spralling H; Smith BL -
Comparing interest in thigh administration of long-acting cabotegravir/rilpivirine among hypothetical users, early adopters and trial participants with experience.
Clin Infect Dis
06/25/2025 Authors: Collins LF; Christopoulos KA; McNulty MC; Colasanti JA -
Brief Report: Improving Perinatal HIV Care During the COVID-19 Pandemic: Implementing a Mobile Integrated Health Program to Close the Gap.
J Acquir Immune Defic Syndr Volume: 99 Page(s): 138 - 142
06/01/2025 Authors: Ramakrishnan A; Goldstein M; Shetty S; Badell M; Kalokhe AS; Colasanti J; Sumitani J; Thomas-Seaton L; Beaupierre M; Hussen SA -
The Association of Anemia on Non-AIDS-Defining Cancer and Subsequent Survival Among People With HIV After Antiretroviral Initiation.
J Acquir Immune Defic Syndr Volume: 99 Page(s): 175 - 184
06/01/2025 Authors: Lang R; Coburn SB; Gill MJ; Grossman J; Mayor A; Horberg MA; Silverberg MJ; Rabkin CS; Moore RD; Kirk GD -
Changes in the prevalence of non-AIDS conditions among hospitalized persons with HIV in the United States and Canada, 2008-2018.
Clin Infect Dis
04/02/2025 Authors: Davy-Mendez T; Napravnik S; Hogan BC; Eron JJ; Gebo KA; Althoff KN; Moore RD; Silverberg MJ; Horberg MA; Gill MJ -
Project RETAIN: Providing Integrated Care for People With HIV Who Use Cocaine.
Open Forum Infect Dis Volume: 12 Page(s): ofaf104
04/01/2025 Authors: Metsch LR; Feaster DJ; Gooden LK; Pan Y; Parish CL; Waldrop D; Rodriguez A; Colasanti JA; Armstrong WS; Root C -
Identifying preferred program delivery attributes for long-acting injectable cabotegravir-rilpvirine in three U.S. HIV clinics: A discrete choice experiment.
J Acquir Immune Defic Syndr
03/13/2025 Authors: Gutierrez JI; Montgomery ET; Dilworth SE; McNulty MC; Colasanti JA; Johnson MO; Koester KA; Sauceda JA; Erguera XA; Dance K -
Enhancing Hepatitis B Virus Vaccine Uptake and Immunity Through Long-Acting Antiretroviral Therapy Programmatic Synergy in the US South.
Open Forum Infect Dis Volume: 12 Page(s): ofaf096
03/01/2025 Authors: Ochieng E; Robinson V; Anderson E; Niles-Carnes L; Smith BL; Armstrong WS; Lora M; Colasanti JA; Collins LF -
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
Clin Infect Dis
01/28/2025 Authors: Marcus JL; Weddle A; Kelley CF; Agwu A; Montalvo S; Sherman E; Vijayan T; Gutierrez J; Hickey MD; Dilworth SE -
Missed and Delayed Diagnoses of Acute Human Immunodeficiency Virus (HIV) Infection in a Southern Opt-Out HIV Testing Environment Without Reflex HIV RNA Testing.
Open Forum Infect Dis Volume: 12 Page(s): ofae684
01/01/2025 Authors: Gruber SF; Wilber EP; Smith B; Rebolledo PA; Colasanti JA; Iytha R; Schwinne M; Robichaux C; Lora MH